Qiagen has secured funding from a US government agency to develop a new test kit for COVID-19.
Qiagen NV has received funding from the US Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) for a new COVID-19 test kit, the company announced 13 March.
Qiagen said its QIAstat-Dx solution is the first syndromic testing product selected for development through ASPR's Biomedical Advanced Research and...
Create an account to read this article
Already a subscriber?
“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.
Medtronic, Tandem and Beta Bionics are gearing up to bring tubeless patch pumps to market, chasing Insulet’s Omnipod 5, the only FDA-cleared patch pump for type 1 and type 2 diabetes. Analysts expect tubeless models to eventually displace durable pumps.
Leaders of robotic systems companies Distalmotion, Neocis and Noah Medical discussed success metrics, competition and funding. Institutional investors are focusing on utilization, procedure rates and a clear path to profitability as the IPO window reopens, BTIG analyst Ryan Zimmerman said.
